|
|
|
|
| LEADER |
03252nam a22003855i 4500 |
| 001 |
000281636 |
| 005 |
20210721132005.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120919s2013 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781461441182
|
| 024 |
7 |
|
|a 10.1007/978-1-4614-4118-2
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Complement Therapeutics /
|c edited by John D. Lambris, V. Michael Holers, Daniel Ricklin.
|
| 250 |
|
|
|a 1st ed. 2013.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2013.
|
| 300 |
|
|
|a VIII, 320 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 735
|
| 505 |
0 |
|
|a Progress and Trends in Complement Therapeutics -- Inhibition of the serine proteases of the complement system -- The role of MASP-1/3 in complement activation -- Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE -- DAF as a therapeutic target for steroid hormones: implications for host pathogen interactions -- Targeting gC1qR domains for therapy against infection and inflammation -- The Alternative C5a Receptor Function -- The effects of selective complement- and CD14-inhibition on the E. coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and tissue factor functional activity in human whole blood -- CR2-Mediated Targeting of Complement Inhibitors: Bench-to-Bedside Using a Novel Strategy for Site-Specific Complement Modulation -- Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anti-complement strategies -- Defective Complement Action and Control Defines Disease Pathology for Retinal and Renal Disorders and Provides a Basis for new Therapeutic Approaches -- C3 Glomerulonephritis/CFHR5 Nephropathy is an endemic disease in Cyprus: Clinical and molecular findings in 21 families -- Complement-targeted therapeutics in periodontitis -- Complement system activation in cardiac and skeletal muscle pathology: Friend or foe? -- Innate immunity as orchestrator of bone marrow homing for hematopoietic stem/progenitor cells -- Complement-mediated microvascular injury leads to chronic rejection -- Targeting complement at the time of transplantation -- Evaluation of the blood compatibility of materials, cells and tissues: Basic concepts, test models and practical guidelines -- Non-invasive detection of complement activation through radiologic imaging -- Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics and Therapeutics -- Complement in Action: A Review of Patent Trends From 1976 through 2011.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
0 |
|a Infectious diseases.
|
| 650 |
|
0 |
|a Pathology.
|
| 650 |
1 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Microbiology.
|
| 650 |
2 |
4 |
|a Infectious Diseases.
|
| 650 |
2 |
4 |
|a Pathology.
|
| 700 |
1 |
|
|a Lambris, John D.
|e editor.
|
| 700 |
1 |
|
|a Holers, V. Michael.
|e editor.
|
| 700 |
1 |
|
|a Ricklin, Daniel.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|